Clovis Oncology Stock Boosted By Promising Regulatory Update

A short squeeze could push CLVS even higher

Managing Editor
Feb 22, 2018 at 10:25 AM
facebook X logo linkedin


Clovis Oncology Inc (NASDAQ:CLVS) stock is up 7.4% to trade at $59 this morning, after the company received a positive trend vote from a European Union (EU) committee for its ovarian cancer drug marketing application. In response, RBC upgraded CLVS stock to "outperform" from "sector perform," while cutting its price target to $72 from $80. The analyst in coverage is calling for a positive outcome when the official vote is taken next month, and predicts a strong launch for the treatment in the U.S. during the second quarter.

Clovis stock is on track for its best day in months, but is struggling to overcome the 50-day moving average that's contained the past two breakout attempts. The equity is also trading right near its year-over-year breakeven level as it tries to recover the losses it's suffered since peaking just below the century level back in July.

A short-squeeze that could provide tailwinds for the security. Short interest increased by 6% during the last reporting periods, and accounts for nearly 17% of CLVS's total available float. This represents nearly one week of pent-up buying demand.

Whether you're expecting a pullback or extended upside, it's a good time to speculate on CLVS with short-term options. That is, the stock has a Schaeffer's Volatility Index (SVI) of 58%, which sits just 12 percentage points from a 52-week low, hinting at lower-than-usual volatility expectations for near-term contracts. This is especially surprising since the company is slated to report earnings after the close on Monday.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI